![]() |
市場調查報告書
商品編碼
1987124
攜帶式氧氣濃縮機市場規模、佔有率、趨勢和預測:按技術、應用、最終用戶和地區分類,2026-2034年Portable Oxygen Concentrators Market Size, Share, Trends and Forecast by Technology, Application, End User, and Region, 2026-2034 |
||||||
2025年全球攜帶式氧氣濃縮機市場規模為20億美元。展望未來,IMARC Group預測,該市場將在2026年至2034年間以6.62%的複合年成長率成長,到2034年達到36億美元。目前,北美是該市場的主要驅動力,在2025年佔據超過38.9%的市場。該市場的主要促進因素包括慢性阻塞性肺病(COPD)、氣喘和囊腫纖維化等呼吸系統疾病的日益普遍、老年人口的成長以及人們對居家醫療日益成長的興趣。
肺氣腫和慢性阻塞性肺病(COPD)等呼吸系統疾病的日益普遍,推動了攜帶式氧氣濃縮機(POC)市場的成長。隨著老齡化,人們更容易患上慢性呼吸系統疾病。此外,攜帶式氧氣濃縮機技術的進步提高了效率,延長了電池續航力,並使其設計更加輕巧緊湊。這滿足了那些希望在接受治療的同時保持行動自由和獨立性的使用者的需求。市場趨勢反映出,由於居家照護方案比住院治療更具成本效益和便利性,人們越來越傾向於選擇居家照護方案。為了因應這一轉變,製造商正致力於創新攜帶式製氧機,以滿足不同患者的個人需求。此外,新興市場醫療基礎設施的改善和氧氣療法活動的加強,也促進了攜帶式設備的普及。隨著數位健康工具的廣泛應用,包括與行動應用程式連接以實現遠端監測和調節在內的智慧技術整合也正在加速發展。最後,已開發國家政府為醫療設備提供補貼和報銷的舉措,也正在改善市場准入。這些促進因素和趨勢綜合起來,凸顯了市場向先進、方便用戶使用且易於獲得的攜帶式氧氣濃縮機發展的方向。
美國正崛起為攜帶式氧氣濃縮機的主要區域市場。由於人口老化和環境因素導致慢性阻塞性肺病(COPD)和氣喘等呼吸系統疾病的盛行率不斷上升,美國攜帶式氧氣濃縮機市場持續成長。不斷上漲的醫療保健成本以及患者對居家照護的偏好,加速了攜帶式氧氣濃縮器的普及,這些設備為氧氣療法提供了便利性和移動性。輕巧的設計、超長壽命電池以及應用程式連接等智慧功能等技術創新正在塑造市場趨勢。此外,政府支持醫療保險報銷的政策也擴大了這些設備的使用範圍。隨著以價值為基礎的醫療模式和個人化醫療的興起,越來越多的患者需要這些先進的、以使用者為中心的氧氣濃縮器。人們對呼吸系統健康的日益關注以及對提高患者生活品質不斷成長的需求,也是推動市場發展的積極因素。
呼吸系統疾病病例增加
隨著肺癌、慢性阻塞性肺病(COPD)、氣喘、肺纖維化和流感等呼吸系統疾病患者數量的不斷增加,對高效能氧氣療法系統的需求也日益成長。根據世界衛生組織估計,全球約有5.45億人患有慢性呼吸系統疾病,包括COPD、氣喘和肺纖維化,這意味著龐大的潛在氧氣療法患者群體。處方制氧機(POC)提供便利的攜帶式氧氣供應,幫助患者更好地管理病情,並提高生活品質。呼吸系統疾病的日益普遍推動了市場對POC的需求成長。此外,POC使醫護人員能夠在醫院外(例如在家中)提供護理,從而減輕醫院的負擔。而且,與其他傳統氧氣療法相比,POC成本更低,因為它無需頻繁地補充氧氣瓶和維護固定式製氧機。
對居家醫療的需求日益成長
隨著居家醫療需求的日益成長,治療過程中醫療設備的便攜性變得愈發重要。攜帶式氧氣濃縮器(POC)完美契合這一需求,讓氧氣療法在家中輕鬆便捷地進行。歐洲呼吸學會2022年的調查顯示,60%的慢性呼吸道疾病患者更傾向於居家照護而非住院治療,主要原因是居家照護的便利性和舒適性。在居家照護趨勢不斷增強的背景下,攜帶式氧氣濃縮機的需求也達到了頂峰。此外,居家醫療可以透過縮短住院時間、減少再入院率和急診就診次數來降低醫療保健系統的成本。氧氣濃縮機氧氣濃縮器使患者能夠攜帶式接受氧氣療法,從而降低因呼吸系統疾病住院的可能性。醫療資源的最佳化利用和成本效益的提升正在推動攜帶式氧氣濃縮器在居家照護策略中的應用。
人口老化的過程
隨著老齡化,慢性阻塞性肺病(COPD)、肺炎及其他肺部疾病等呼吸道疾病的風險也隨之增加。這些疾病通常需要長期氧氣療法來緩解症狀並提高生活品質(QOL)。老年人口的成長與呼吸系統疾病的盛行率上升直接相關。因此,對床邊氧療(POC)的需求日益成長,POC是氧氣療法必不可少的醫療設備。例如,根據歐盟委員會統計,2023年歐洲老年人口數量顯著增加。在該地區,65歲及以上人口占總人口的21.3%以上。 POC也確保了移動性和便攜性,使老年人能夠在積極生活和維持原有生活方式的同時獲得必要的氧氣供應。由於老年人「積極老化」的趨勢日益明顯,對能夠幫助老年人充分參與其所願活動的POC的需求也在進一步成長。
The global portable oxygen concentrators market size was valued at USD 2.0 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 3.6 Billion by 2034, exhibiting a CAGR of 6.62% from 2026-2034. North America currently dominates the market, holding a significant market share of over 38.9% in 2025 . The major factors driving the market are the rising cases of respiratory diseases such as chronic obstructive pulmonary disease, asthma, and cystic fibrosis, rising geriatric population and growing affinity for home-based medical treatment.
The growing incidence of respiratory conditions like emphysema and chronic obstructive pulmonary disease (COPD) is propelling the market for portable oxygen concentrators (POCs). With age, more people are becoming vulnerable to chronic respiratory issues. The portable oxygen concentrator technology has also seen its advancements with regards to increased efficiency with longer battery life and reduced and lighter designs that increase user appeal for the need for mobility and independence while receiving treatment. Market trends reflect increased preference toward home-based care solutions since they are cost-effective and convenient as opposed to a hospital stay. This shift has prompted the manufacturers to innovate POCs to meet patient-specific needs. In addition, the increasing adoption of portable devices in the emerging market is backed up by improved healthcare infrastructure and the spreading of awareness programs for oxygen therapy. The integration of smart technologies, including connectivity to mobile applications for remote monitoring and adjustment, is gaining momentum in tandem with the increasing adoption of digital health tools. Additionally, government initiatives that provide subsidies and reimbursements for medical devices in developed countries improve market access. These drivers and trends collectively underscore the market's direction toward advanced, user-friendly, and accessible portable oxygen concentrators.
The United States has emerged as a key regional market for portable oxygen concentrators. The United States portable oxygen concentrators market is growing due to the increasing prevalence of respiratory conditions like COPD and asthma, driven by aging demographics and environmental factors. Increasing healthcare spending and patient preference for home-based care are accelerating the adoption of portable devices, offering convenience and mobility for oxygen therapy. Technological innovations including lightweight designs, extra-long battery life, and smart features like app connectivity are molding the market trends. Further, the government policies supporting Medicare reimbursement have widened access to these devices. With the value-based care model and personalized treatment, more patients need such advanced, user-oriented concentrators. Higher consciousness toward respiratory health and increasing desire for a better quality of patients' lives are also positive contributors to the market.
Increasing cases of respiratory conditions
The increasing cases of patients diagnosed with respiratory conditions such as lung cancer, COPD, asthma, pulmonary fibrosis, and flu require an efficient oxygen therapy system. As reported by WHO, it is estimated that 545 million people suffer from chronic respiratory diseases, including COPD, asthma, and pulmonary fibrosis, thus forming a vast potential patient base for the requirement of oxygen therapy. POCs provide convenient and portable oxygen delivery to patients with the ability to care for their conditions and improve their overall quality of life. Increases in respiratory disease incidence rates account for the growth in POC demand in the market. Additionally, POCs allow healthcare providers to administer care outside the walls of the hospital by delivering care in the home thus alleviating the burden on the hospitals. In addition, POCs also are a low-cost option as compared with other conventional oxygen therapy methods where frequent refills of cylinders or maintenance of stationary concentrators are done away with.
Growing demand for home medical care
The increasing need for home medical care grows the demand to have portability in medical devices at the time of treatment. POCs fit well within this need as they allow for the easy and portable use of oxygen therapy within a home setting. According to the European Respiratory Society, in 2022 it was revealed that 60% of patients with chronic respiratory diseases prefer to be cared for at home rather than within a hospital, citing convenience and comfort as major factors. With this growing trend toward care at home, the increasing need for portable oxygen concentrators is at its peak. In addition, home-based medical care can potentially save healthcare systems money in terms of decreasing hospital stays, readmissions, and emergency department visits. POCs allow patients to receive oxygen therapy at home, which reduces the likelihood of being admitted to a hospital due to respiratory disease. Optimization of healthcare resources and cost-effectiveness drive the integration of POCs into home-based care strategies.
Increasing geriatric population
As people age, their susceptibility to respiratory diseases such as chronic obstructive pulmonary disease, pneumonia, and other lung disorders increases. These conditions typically require long-term oxygen therapy to alleviate symptoms and enhance the quality of life. The increasing geriatric population directly contributes to the increased prevalence of respiratory diseases. As a result, POCs are in greater demand as a necessary medical device for oxygen therapy. For example, according to the European Commission, the number of elderly increased dramatically in Europe in 2023 as well. More than 21.3% of people above 65 years made up the entire population in that region. Also, POCs ensure mobility and portability that enables elderly people to live actively and carry on with their lifestyles, and in doing so, receive the necessary oxygen supply. The aspiration for active aging by the geriatric population fuels the demand for POCs that enable them to participate fully in their desired activities.
In 2025, pulse flow represents the leading segment with 69.5% of the portable oxygen concentrators market share. The delivery of oxygen makes an oxygen flow that would go synchronized with breathing by a patient, with low oxygen wastage that contributes to higher usability of this type of technology, valued because of its lightweight design that contributes to portability. It is suitable for active patients requiring mobility during oxygen therapy. This segment has been further strengthened by innovations such as longer battery life, compact form factors, and advanced sensors that adapt to varying respiratory patterns. Pulse flow devices cater to the growing preference for home-based care and ambulatory use, especially among individuals with chronic respiratory conditions. Moreover, the integration of smart features, including app-based monitoring and real-time adjustments, has elevated user experience and encouraged adoption. The increasing prevalence of chronic respiratory diseases, coupled with technological advancements and awareness about portable oxygen solutions, continues to propel this segment's growth and reinforce its market leadership.
COPD dominates the segment and holds a 43.2% market share since this chronic condition has a high prevalence globally. As a result, patients using COPD often require supplemental oxygen therapy for the elongated periods to control and improve their quality of life. The portable oxygen concentrators will be of great importance, as these patients cannot use an oxygen tank for mobility since it has limited space. The aging population, more vulnerable to COPD, is a prime growth driver for this market. Increased awareness campaigns of the importance of early diagnosis and treatment are also contributing to wider adoption. The device manufacturers are tailoring products to meet COPD-specific needs, integrating features such as adjustable oxygen flow rates, extended operating times, and lightweight designs. In addition, the trend toward affordable, home-based care options has increased demand for portable oxygen concentrators among COPD patients.
Ambulatory surgery centers hold the largest market share, which is an emerging trend toward outpatient care as it is more cost-effective and convenient. The centers often use portable oxygen concentrators for pre-operative and post-operative respiratory support in patients with chronic underlying conditions, such as COPD. The portability and mobility of these devices are best suited for ASCs where space and efficiency are critical. The growth in the number of ASCs and the trend toward delivering high-quality care in shorter patient stays have played a significant role in ASC dominance. Portable concentrators allow for faster patient recovery and turnover, which meets the operational needs of an ASC. There is an increasing trend toward minimally invasive procedures, which require oxygen support for respiratory stability, increasing demand. Technological improvements through compact designs and user-friendly interfaces enhance adoption. With healthcare trends being set in favor of outpatient settings versus traditional hospital care, portable oxygen concentrators in the ASC continue to gain relevance and establish further leadership within this segment.
In 2025, North America held the largest portable oxygen concentrators market share with 38.9%. North America hosts a high prevalence of respiratory diseases, including COPD, asthma, and other lung conditions. The region's demographic aging, environmental factors, and lifestyle choices contribute to higher rates of respiratory conditions. The higher incidence rate of such diseases leads to the creation of a larger patient group, who require oxygen therapy in the given region. Therefore, there will be a hike in demand for POCs in North America. Also, the region houses well-established healthcare infrastructure, especially high-quality medical facilities, a better health system, and the required funds for healthcare-related research and development. A superior class of hospitals, clinics, and ambulatory surgery centers provide an enhanced platform for the acceptance of POCs. Moreover, the POC market experienced relentless technological advancements, during which North America was always at the forefront of those developments. The region has several key players in the health care and medical device industry which creates a culture of research and development.
The Asia Pacific portable oxygen concentrators market is growing due to the prevalence of respiratory disease and the graying population across the region. Rapid urbanization leads to increased levels of air pollutants, which creates a greater incidence of COPD and asthma, boosting demand. Additionally, the rapid development of the health infrastructure and improving awareness about the use of oxygen therapy propel this market growth. The most important drivers in this region are government initiatives to enhance access to medical devices, as well as the growing popularity of homecare solutions, particularly in emerging markets such as China and India.
The European portable oxygen concentrators market is driven by a high prevalence of chronic respiratory conditions and a growing elderly population. Increasing awareness about early diagnosis and oxygen therapy encourages adoption. The expansion of the market is also supported by favorable reimbursement policies across countries such as Germany, France, and the UK. Technological advancements in medical devices and the region's focus on home-based care solutions further increase demand. Furthermore, increasing healthcare expenditure and the drive to promote respiratory health are pushing the market, with a growing emphasis on patient-centric, portable healthcare solutions.
The market for portable oxygen concentrators in Latin America is increasing as respiratory diseases, including COPD and asthma, continue to rise because of pollution and smoking rates. The economies of countries like Brazil and Mexico have improved healthcare accessibility and affordability, increasing the demand for sophisticated medical equipment. Increased awareness campaigns and acceptance of homecare oxygen therapy have become crucial factors. In addition, investments in healthcare infrastructure and the increasing availability of compact, cost-effective portable concentrators are further supporting market growth in the region.
The market is growing in the Middle East and Africa due to increased awareness about respiratory health and a growing prevalence of conditions such as asthma and COPD. Main Enablers of Improvement in Healthcare Infrastructure and Economic Development, particularly in Countries like UAE and South Africa Adoption of Home-Based Oxygen Therapy Solutions, with Help from the Governments to Improve Medical Devices and Further Enhanced Availability due to Increased Partnering with International Manufacturers as Well as Local Distributors Across This Region.
UNITED STATES PORTABLE OXYGEN CONCENTRATORS MARKET ANALYSIS
The United States accounts for 80% of the portable oxygen concentrators market in North America. Advanced healthcare infrastructure and high prevalence of chronic respiratory conditions help the U.S. portable oxygen concentrators market. The Centers for Disease Control and Prevention (CDC) reported that around 16 million Americans have chronic obstructive pulmonary disease (COPD), leading to demand for oxygen therapy devices. Medicare reimbursement policies also enhance affordability and adoption. Market leaders like Inogen and Invacare drive the market through technological innovation in lightweight, battery-powered models. Awareness about respiratory health and government support for homecare solutions are the other factors driving growth. Canada and Mexico export opportunities increase the U.S. share as an important international player in the global market for portable oxygen concentrators.
EUROPE PORTABLE OXYGEN CONCENTRATORS MARKET ANALYSIS
The growth of the European market for portable oxygen concentrators is closely related to both the growing demand for long-term oxygen therapy and the changing clinical practices that are increasingly based on individualized care. According to the 2023 European Lung Foundation report, many people in Europe use long-term oxygen therapy, thus directly creating a need for portable devices. This is in line with the trend of individualizing oxygen prescriptions that have emerged in clinical practice and are widely done in countries such as Italy, France, and the Netherlands. For example, according to the European Respiratory Society, in Italy, 67% of respirologists screen patients at night to tailor nocturnal prescriptions, a practice also reflected in the increased use of portable oxygen devices. The strategy is an even more significant trend toward personalization of treatment, to which the growth of e-commerce sites such as Amazon and Mediq, providing greater access to patients, contributes. Moreover, more aggressive goals for Sa, O2 levels, such as the 35% in Spain and 36% in Italy targeting >=92%, are linked to the enhanced complexity of portable oxygen concentrators, which are intended to be more patient-specific. This is part of the USD 36 Billion in medical devices allocated in Germany's 2022 healthcare budget, clearly reflecting investment in respiratory care equipment, including portable oxygen concentrators. The demand for this is supported by regulatory standards and public health awareness campaigns, so ensuring that both safety and accessibility gains the trust of patients in the devices. This correlation between the growing number of respiratory illness cases, individualized oxygen prescriptions, and innovation in portable oxygen technology is driving the growth of the market in Europe.
ASIA PACIFIC PORTABLE OXYGEN CONCENTRATORS MARKET ANALYSIS
The Asia Pacific portable oxygen concentrator market is expanding significantly as a result of rising healthcare costs and the high incidence of respiratory illnesses. The WHO estimates that more than 100 million in China suffer from COPD, which leads to demand for oxygen therapy equipment. The Chinese government allocated a sum of 1.5 Billion USD toward medical equipment during the year 2023 as part of its medical reform. Making in India-India has motivated domestic production, reduced costs, and increased availability. Panasonic, one of the Japanese major manufacturers, is now releasing premium models with innovative features to satisfy the needs of technology-conscious customers. Additionally, the association between global companies and local distributors allows the product to access a wider range of consumers. Malaysia and Thailand are now increasingly witnessing medical tourism, thereby increasing the demand for portable oxygen concentrators. Tie-ups between global companies and local distributors also ensure that the product reaches more consumers.
LATIN AMERICA PORTABLE OXYGEN CONCENTRATORS MARKET ANALYSIS
The portable oxygen concentrators market is emerging in Latin America due to rising healthcare investment and the prevalence of respiratory diseases in the region. International Trade Government cited Brazil as the largest healthcare market in this region as it spent 9.47% of its GDP on healthcare. This high investment boosts access to modern medical devices, which in this case includes an oxygen concentrator. The International Pharmaceutical Federation reports that over 6.3 million people in Brazil suffer from COPD and this amounts to a huge market for portable oxygen therapy. Government initiatives like Mexico's Seguro Popular offer subsidies to increase the adoption rates within the region. This encourages big players like Philips and GCE Group to launch energy-efficient models that are affordable to meet regional needs. Latin America will be a growth region for portable oxygen concentrators, with increasing market demand due to an improving healthcare infrastructure and rising demand for home healthcare services.
MIDDLE EAST AND AFRICA PORTABLE OXYGEN CONCENTRATORS MARKET ANALYSIS
The increased incidence rates of respiratory ailments and the interest by the governments to improve health care drive the demand for portable oxygen concentrators across the Middle East and Africa. The International Respiratory Foundation puts the regional prevalence of the entire patient population with COPD to be more than 6 Million. Saudi Arabia dedicated USD 5 Billion in 2023 for health sector modernization in purchasing oxygen concentrators and other health products within Vision 2030. One of South Africa's home-based manufacturers is Afrox. They provide patients with home-based medical products very reasonably. The rise of home care products in the cities of Egypt and the United Arab Emirates is leading to a boost in demand. Strategic collaborations with overseas producers are making products more available and affordable and therefore spur growth in the regional market.
Key players are emphasizing innovation and strategic plans as they look to meet increased demands for efficient and user-friendly devices. The key companies in the portable oxygen concentrator industry are investing substantially in research and development. Technologically advanced products would feature extended battery life, greater portability, and the use of smart technologies such as Bluetooth connectivity and mobile app monitoring. One important trend, that involves a lot of partnerships and collaboration, is where companies form agreements to bolster their networks, expand their presence, and push into worldwide markets. As is the case with players like several being aligned to providers for smooth availability in healthcare systems, home care service providers for easy use, and awareness about adoption, among other combinations. It is through merger and acquisition wherein companies continue strengthening their offerings and geographical markets. In regions such as North America and Europe, which are highly regulated, companies are focusing on obtaining regulatory approvals and certifications to comply with healthcare standards. Most companies are also targeting emerging markets by offering cost-effective solutions to budget-conscious consumers. The combination of innovation, strategic alliances, and geographic expansion underscores the proactive approach of market players to capitalize on the increasing demand for portable oxygen concentrators.